<Anchor>
US pharmaceutical company Modena announced that the final clinical trial of its vaccine showed 94.1% effectiveness.
The U.S. government says vaccinations could start even before Christmas this month.
This is Choi Ho-won.
<Reporter>
More than 30,000 people participated in the Phase 3 clinical trial of Modena vaccine.
Of these, 196 people were infected with Corona 19, and among the confirmed cases, 11 were vaccinated with Modena.
Modena says the vaccine is effective at 94.1 percent.
In particular, none of the vaccinations were severely ill.
Modena immediately applied for emergency use approval from the US Food and Drug Administration FDA and the European Medicines Agency EMA.
The FDA will first hold an advisory committee meeting on the 10th and deliberate on Pfizer's vaccine that applied for emergency use on the 20th of last month.
Modena said the FDA would review its vaccine on the 18th, a week later.
[Steve Bangsell/Moderna CEO: We will produce 20 million batches by the end of this year.
After the emergency use authorization will be immediately distributed to the country, trying to feed within 24 hours of approval.]
And the US Secretary of Health and Human Services to Alex, "The Pfizer and Moderate or two vaccine may be this year's administration to Christmas all Americans." Said.
It is known that the Korean government plans to secure two vaccines, Pfizer and Modena, through COVAX, an international vaccine partnership.